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1. Introduction  
Cervical intraepithelial neoplasia (CIN) is a premalignant cervical disease that is also called 
cervical dysplasia or cervical interstitial neoplasia or cervical squamous intraepithelial 
lesions (CSIL). 
The nomenclature in use in the past was mild, moderate, and severe dysplasia, these were 
the terms used to describe premalignant squamous cervical cellular changes. Although still 
in use by some, it has generally been replaced by the term Cervical Intraepithelia 
Neoplasia(CIN), which is used to describe histologic changes on the uterine cervix. The 
trend is now tending towards the use of Squamous Intraepithelia Lesions(SIL).   
1.1 Definition 
What is cervical intraepithelial Neoplasia-? It is a potentially premalignant transformation 
and abnormal growth (dysplasia) of squamous cells on the surface of the cervix.[Kumar etal 2007] 
CIN is not cancer, and is usually curable.[ACOG 2010] Most cases of CIN remain stable, or are 
eliminated by the host's immune system without intervention. However a small percentage 
of cases progress to become cervical cancer, usually cervical squamous cell carcinoma (SCC), 
if left untreated.[Agorastos et al 2005] 
It can actually be defined as a spectrum of intraepithelial changes (dysplasia) with indistinct 
boundaries that begins with mild atypia and progresses through stages of more marked 
intraepithelial abnormalities to carcinoma in situ if untreated or managed. (UVA Health) 
1.1.1 Dysplasia is a potentially reversible change characterized by an increase in mitotic 
rate, atypical cytologic features (size, shape, nuclear features) and abnormal organization 
(cellularity, differentiation, polarity) that fall short of invasive carcinoma (premalignant 
change).Dysplasia may progress to cancer and dysplastic changes may be found adjacent to 
foci of cancer. 
1.2 Epidemiology 
Population distribution of cervical intraepithelial neoplasia/dysplasia resembles the 
epidemiology of an infectious disease that is sexually transmitted. Multiple male sexual 
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partners, early age at first sexual intercourse and male partner with multiple 
previous/current female sexual partners are very important risk factors. 
1.3 Incidence 
The estimated annual incidence in the United States of CIN among women who undergo 
cervical cancer screening is 4 percent for CIN 1 and 5 percent for CIN 2,3 [Agorastos et al 
2005]. High grade lesions are typically diagnosed in women 25 to 35 years of age, while 
invasive cancer is more commonly diagnosed after the age of 40, typically 8 to 13 years after 
a diagnosis of a high grade lesion. Between 250,000 and 1 million American women are 
diagnosed with CIN annually. Women can develop CIN at any age, however, women 
generally develop it between the ages of 25 to 35.[ Kumar etal 2007] 
In developing Nations like Nigeria the mean age for cervical intraepithelial neoplasia (CIN) 
was 37.6 years. CIN I accounted for 3.6%, CIN II 0.8% and CIN III was only 0.4%.The 
combined prevalence was 48 per 1000.The peculiarity of the developing nations result is the 
poor uptake or use of screening methods(Oguntayo & Samaila). 
In view of the fact that CIN is a premalignant or precursor of cervical cancer it is pertinent to 
briefly see the incidence and prevalence of this disease condition. 
Cervical cancer is second only to breast cancer in its incidence world wide. Cancer registry 
data shows that that there are approximately 400,000 new cases of cervical cancer and 
200,000 deaths from this disease every year (IARC 2001). 
The incidence rate varies from country to country with eighty percent (80%) of the cases 
occurring in less developed countries. The reasons for this may lie in the   socio economic 
conditions that prevail in these countries where facilities for family planning, obstetric and 
gynaecological health care are scarce and cervical screening programmes are virtually non 
existent. (IARC 2001). 
The relative incidences of cervical intra-epithelial neoplasia (CIN) and invasive cervical 
cancer were studied in black and white patients at the academic hospitals of the University 
of the Orange Free State. A statistically high significant differences was found between black 
and white patients, with a higher incidence of invasive cervical cancer than stage III CIN 
(CIN III) in black patients and a higher incidence of CIN III than invasive cervical cancer in 
white patients (P=0,000092; 95% confidence interval -0,355 - -0,128). The time interval 
between the peak incidence of CIN III and that of invasive cervical cancer was found to be 
shorter in black than in white patients. These distressing findings emphasise the urgent 
need for a national cervical cytological screening programme to decrease the incidence of 
invasive cervical cancer (NEL1994) 
2. Anatomy 
2.1 Anatomy of the uterine cervix  
The cervix is actually the lower, narrow portion of the uterus, connected to the uterine 
fundus by the uterine isthmus. Its name is derived from the Latin word for "neck." It is 
cylindrical or conical in shape. Its upper limit is considered to be the internal os, which is an 
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anatomically and histologically ill-defined junction of the more muscular uterine body and 
the denser, more fibrous cervical stroma. The size and shape of the cervix varies widely with 
age, hormonal state, and parity. In parous women, the cervix is bulkier and the external os, 
or lowermost opening of the cervix into the vagina, appears wider and more slit-like and 
gaping than in nulliparous fig 2 women. Before childbearing, the external os is a small, 
circular opening at the center of the cervix fig 1. After the menopause it may narrow almost 
to a pin point fig 3. The portion of the cervix exterior to the external os is called the 
ectocervix. The passageway between the external os and the body of the uterus at the 
isthmus above is referred to as the endocervical canal. Its upper limit is the internal os.5 
 
Fig. 1. The nulliparous cervix: note the small round os  
  
Fig. 2. Multiparous cervix   
  
Fig. 3. Menopausal cervix  
www.intechopen.com
 Intraepithelial Neoplasia 282 
The canal itself shows a complex configuration of mucosal folds or plicae. These make 
cytologic screening and colposcopy of the endocervical tissues technically more difficult and 
less reliable than for the smoother and more accessible squamous epithelium of the 
ectocervix.(ASCCP 2011) 
2.2 Embryology of the uterine cervix 
Two paramesonephric ducts form from coelomic epithelium extending beside the 
mesonephric ducts. In the absence of Mullerian Inhibitory Factor these ducts proliferate and 
grow extending from the vaginal plate on the wall of the urogenital sinus to lie beside the 
developing ovary. The paired ducts begin to fuse from the vaginal plate end, forming the 
primordial body of the uterus and the unfused lateral arms form the uterine tubes.see fig 4 
The picture bellow is the summary of the embryonic development of the uterine cervix 
and the second is showing the infantine uterus as it appears and this is an evidence that 
there are significant changes that do occur as the girl child grows fig 5.The main clinical 
reference to this is basically in the epithelia changes between pre pubertal and post 
pubertal period.The epithelia lining of the cervical canal (endocervix) is the columnar 
epithelium while that of external cervix (endocervix) is squamous epithelium. The 
squamo-columnar junction is located at the point where the squamous epithelium and the 
columnar epithelium meet. The location varies throughout a woman’s life due to the 
process of metaplastic changes in the cervical epithelium which occur after puberty and in 
pregnancy.(Mark 2010) 
 
 
 
Fig. 4. Embryological Origin of the Uterus  
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Fig. 5. 
2.3 Cervix-normal histology 
Most of the cervix is composed of fibromuscular tissue. The Epithelium is either squamous 
or columnar. 
The endocervix  is  lined by columnar epithelium that secretes mucus this epithelium has 
complex infoldings that resemble glands or clefts on cross section and the mucosa rests on 
inconspicuous layer of reserve cells. 
The ectocervix (exocervix)is covered by nonkeratinizing, stratified squamous epithelium, 
either native or metaplastic; has basal, midzone and superficial layers. A fter menopause 
and in prepubertal girls the superficial layer becomes  atrophic with mainly basal and 
parabasal cells with high nucleo-cytoplasmic  ratio that resembles dysplasia. 
2.3.1 Squamocolumnar junction: where squamous and glandular (columnar) epithelium 
meets this a major land mark in cervical dyplasia,it is usually in exocervix.The nearby 
reserve cells are involved in squamous metaplasia, dysplasia and carcinoma. 
2.3.2 Transformation zone: also called ectropion, between original squamocolumnar 
junction and border of metaplastic squamous epithelium; epidermalization and squamous 
differentiation of reserve cells transform this area to squamous epithelium; site of squamous 
cell carcinomas and dysplasia. 
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Metaplastic change of endocervical epithelium in the transformation zone 
In the cervix a lot of metaplasia takes place which was what encouraged a lot of study to be 
conducted. 
 Metaplasia is the name given to the process by which one fully differentiated type of 
epithelium changes into another.  
 It is usually an adaptive change which occurs in reaction to longstanding (chronic) 
irritation of any kind, or in response to hormonal stimuli.  
 Metaplastic change is reversible and theoretically transformed epithelium should revert 
to its original form after the stimulus is removed but this does not always happen.  
 Metaplasia occurs at many body sites eg gastric mucosa, bladder,bronchi etc. The 
metaplastic process has been extensively studied in the cervix. 
2.4 Physiology of metaplastic changes on the cervix 
The metaplastic changes seen are related to the following: 
Pre-Puberty, Post puberty, Pregnancy and Menopause. 
Pre-puberty-From birth until puberty the endocervical epithelium is composed of columnar 
epithelium and the ectocervix of native squamous epithelium. The interface between the 
two is termed the original squamocolumnar junction. 
 
Squamocolumnar junction prior to puberty. 
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Puberty-During puberty and at the first pregnancy the cervix increases in volume  in 
response to hormonal changes. The endocervical epithelium everts onto the ectocervix 
(portio vaginalis) exposing it to the acid pH of the vagina. This provides a stimulus for 
metaplastic change of the columnar epithelium. 
 
Eversion of the endocervical epithelium at puberty and first pregnancy  
Menopause-The process of metaplasia is a patchy one: It starts initially in the crypts and at 
the tips of the endocervical villae which gradually fuse. Eventually the whole of the everted 
endocervical epithelium may be replaced by squamous epithelium.  
 
Relocation of SCJ in the endocervical canal after the menopause 
Key: 
 1: native squamous epithelium  
 2: columnar epithelium of endocervix  
 3: squamocolumnar junction (SCJ)  
 4: Eversion of endocervical epithelium  
 5: Metaplastic change in transformation zone (Eurocytology 2011) 
The Clinical significance of squamous metaplasia in the cervix is that, this area of the 
cervical epithelium has under gone metaplasia(Transformation zone) and all the immature 
metaplastic are susceptible to carcinogens.In view of the afore mentioned it is not surprising 
that most cervical cancers arise here.  
www.intechopen.com
 Intraepithelial Neoplasia 286 
2.4.1 Basal cells (reserve cells): cuboidal to low columnar with scant cytoplasm and 
round/oval nuclei; acquire eosinophilic cytoplasm as they mature; positive for low 
molecular weight keratin and estrogen receptor; negative for high molecular weight keratin 
and involucrin 
2.4.2 Suprabasal cells: have variable amount of glycogen, detectable with Lugol/Schiller’s 
test (application of iodine) 
2.4.3 Glandular epithelium: positive for estrogen receptor. 
3. Aetiology  
3.1 Association of human papillomaviruses and cervical Intraepithelia neoplasia 
Human papillomaviruses (HPV) are members of a family of viruses known as 
the  Papovaviruses fig 5. They are epitheliotropic viruses which promote cell proliferation 
which results in the development of benign papillomatous lesions of the genital tract upper 
respiratory tract, digestive tracts and cutaneous lesions of the skin. More than 70 distinct 
HPV types have been identified as a result of molecular hybridisation of DNA extracted 
from condylomata or warty lesions from a variety of sites. Each virus type has a very 
restricted site of infection and viruses which occupy similar niches appear to be genetically 
related. Molecular hybridisation of anogenital warts and cervical biopsies have shown that 
about 30 of the 70 distinct types of HPV are confined to the female genital tract. 
(Eurocytology). 
 
Fig. 6. Electronmicrograph of human papillomavirus (courtesy Eurocytology) 
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DNA analysis of  anogenital warts,CIN and cervical cancerous tissue 
has  shown  that  two   groups of   HPV can be identified in the female genital  tract. One 
group of HPV is   almost always associated with  low grade CIN lesions and exophytic 
anogenital warts which have a low risk  of progressing to cervical cancer.  A second   group 
of viruses is  found most commonly in  CIN2 and CIN3 which have a high risk of developing 
into invasive cancer. 
3.1.1 HPV types found in the female genital tract  
The major cause of CIN is chronic infection of the cervix with the sexually transmitted 
human papillomavirus (HPV), especially the high-risk HPV types 16 or 18(viruses from the 
high risk group (HPV16 and HPV 18) have the ability to immortalise primary human 
keratinocytes ie extend their lifespan) In comparison viruses from the low risk group 
(HPV-6 and HPV -11) do not extend  the life span of transfected human cells which mature 
and die  at the same rate as non infected cells fig 7. Similarly the low risk viruses perform 
poorly in experiments concerned with the malignant  transformation of rodent cells in 
comparison to the high risk HPV types. Moreover, HPV-16 and HPV -18 infected human 
keratinocytes in raft culture (an organotypic culture medium) exhibit a differentiation 
pattern very similar to that seen in vivo in CIN.(Eurocytology). Over 100 types of HPV have 
been identified. About a dozen of these types appear to cause cervical dysplasia and may 
lead to the development of cervical cancer. Other types cause warts. Wikipedia,  
High risk  
  
16,18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68
may lead to Invasive Cancer 
Low risk  
  
6, 11, 42, 44, 53, 54, 62, 66 may lead to
condylomata 
Fig. 7. 
3.2 The viral DNA Integration 
The viral DNA Integration is a consistent  finding in  all cancers harbouring the high risk 
virus types HPV16 and HPV18 and   provides  the strongest evidence that HPV16 and 
HPV18  play an important role in the development of cervical cancer. HPV DNA is present 
in 90% of all cervical invasive cancer. 
It is not sufficient to say that simple infection with high risk HPV or even integration of HPV 
16 /18 into the host cell nucleus is enough for malignant transformation of the cervical 
epithelium.Obviously Infection of the genital tract with HPV 16 is relatively common 
whereas invasive cancer is rare; and integration has been detected in some cases of genital 
warts and CIN lesions. A number of associated-factors have been proposed such 
as  impaired immune response,  persistence of virus, smoking and administration of steroid 
hormones (as oral contraceptives). Other genetic events such as  loss of tumour suppressor 
genes and  the activation of oncogenes may also play a role . Mutations in ras ,fos  and other 
oncogenes have been detected in cervical cancer cell lines but their role in vivo is still to be 
determined.The knowledge of HPV infection has made a remarkable improvement in the 
screening,diagnosis,treatment,prevention and prognosis of cancer of the cervix. 
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Fig. 8. 
3.3 The host immune system and HPV  
The host immunity plays a significant role in the control of this disease entity. The fact that 
HPV remains localised to cervix and vagina further indicates that local immune responses 
are sufficient in controlling and resolving HPV infection. Both cell mediated immunity and 
humoral immunity fig 8. Also immunosuppression has been implicated as an associated 
factor. The majority of infections are transient and not clinically evident with 70-90% of 
infections clearing within 12-30 months. This suggests that host immunity is generally able 
to clear HPV infection. 
4. Histopathological features 
4.1 Histo-pathological changes 
Abnormal cellular proliferation, maturation and atypia characterize cervical intraepithelial 
neoplasia( CIN). Nuclear abnormality is the hallmark of CIN and includes hyperchromasia, 
pleomorphism, irregular borders, and abnormal chromatin distribution. These nuclear 
abnormalities persist throughout the epithelium irrespective of cytoplasmic maturation 
towards the surface. Mitotic rate is increased and abnormal mitotic figures may be seen. 
Histologic grading of CIN is based on the proportion of the epithelium occupied by 
dysplastic cells. The epithelium is divided into thirds.  
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4.2 Grading 
 4.2.1 CIN 1 is considered a low grade lesion. It refers to mildly atypical cellular changes 
in the lower third (basal 1/3) of the epithelium (formerly called mild 
dysplasia/Abnormal cell growth). HPV viral cytopathic effect (koilocytotic atypia) is 
often present. This corresponds to infection with HPV, and typically will be cleared by 
immune response in a year or so, though can take several years to clear. 
 4.2.2 CIN 2 is considered a high grade lesion. It refers to moderately atypical cellular 
changes confined to the basal two-thirds of the epithelium (formerly called moderate 
dysplasia) with preservation of epithelial maturation.  
 4.2.3 CIN 3 is also considered a high grade lesion/Severe dysplasia. It refers to severely 
atypical cellular changes encompassing greater than two-thirds of the epithelial 
thickness, and includes full-thickness lesions (formerly called severe dysplasia or 
carcinoma in situ).  
CIN 1 (mild dysplasia): Dysplastic cells occupy the lower third of the epithelium.fig 9 
 
Fig. 9. 
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CIN 2 (moderate dysplasia): Dysplastic cells occupy up to the middle third of the 
epithelium. See fig 10. 
 
 
 
 
 
 
 
 
 
 
CIN II
 
 
 
 
 
 
 
 
Fig. 10. CIN 2. Note superficial koilocytosis. 
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CIN 3 (severe dysplasia, carcinoma in situ): Dysplastic cells extend into the upper third and 
may occupy the full thickness of the epithelium.fig 11 
 
 
 
 
 
 
 
 
 
 
 
CIN III
 
 
 
 
 
 
 
Fig. 11. CIN3. Note adjacent koilocytes (bottom right)  
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Cytologic grading of CIN also uses a three-tier system. However, the new Bethesda System 
for cytological diagnosis divides precursors of cervical squamous cell carcinoma into low-
grade squamous intraepithelial lesion and high-grade intra-epithelial lesion. 
 
Fig. 12. Pap smear of CIN 1. Note large, dark nuclei, but also large amount of surrounding 
cytoplasm.  
 
Fig. 13. Pap smear of CIN 3. Note large, dark nuclei with a lesser amount of surrounding 
cytoplasm. Compare to superficial cell (lower right hand corner).see fig 12 & 13 
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5. Clinical presentation 
5.1 Clinical appearances 
CIN lesions are characterized by the appearance of white patches on the cervix following 
application of acetic acid. Distinct vascular patterns can be seen on colposcopic examination 
of the cervix in high grade CIN. Lesions occur on the anterior lip twice as commonly as the 
posterior lip. They are found in the transformation zone and areas of squamous metaplasia 
in the endocervix and stop abruptly at the junction with the native portio squamous 
epithelium but can extend along the entire endocervical canal. In general, the portion of CIN 
on the portio surface is low grade (CIN 1) whereas the portion that extends into the 
endocervical canal is high grade (CIN 2 and 3). 
5.2 Clinical behavior 
CIN may regress (spontaneously, especially CIN1), persist or progress. If untreated, up to 
16% of CIN1 will progress to CIN3 and up to 70% of CIN3 will progress to invasive 
squamous cell carcinoma in 1 to 20 years. It is not presently possible to predict which lesions 
will progress. However, the risk of progression to invasive cancer increases and the time 
required is shorter with increasing severity of the lesion.(UVa Health).  
6. Screening 
The aim of screening is to prevent the development of cancer. For screening to be effective, a 
disease should satisfy the following criteria.  
Be common, serious and an important public health concern for the individual and the 
community. 
The disease condition must have a long, latent interval in which pre-malignant change or 
occult cancer can be detected for the case of cancer of the cervix it is 10-15years. 
The natural history of the disease, especially, its evolution from latency to disease should be 
adequately documented. 
There should be effective treatment for pre-malignant change or condition. 
The good news is that cervical cancer screening has satisfies the above criteria, especially 
with regards to developing countries where it really is a public health problem. Cervical 
screening has been shown to be effective in several countries.  
Cervical cancer prevention efforts worldwide have focused on screening women at risk of 
the disease using Pap smears. Treating precancerous lesions has also prevents cervical 
cancer in many of the developed countries. In view of the afore mentioned cancer of the 
cervix is almost extinct in the developed nations,making it the 11th cancer in women and 2nd 
commonest in developing nations.  
6.1 Coverage of the screening programme 
It is recommended for all women; especially aged 20 – 64 are invited for screening.  
It should be carried out every 3-5 years. 
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The screening is carried out every 3years in Women aged 45years and bellow. 
Where as it is done every 5years in Women aged >45yrs. 
Some other risk factors that have been found to be important in developing CIN that would 
benefit from screening includes(Kumar et al 2007) 
 Women who become infected by a "high risk" types of HPV, such as 16, 18, 31, or 45  
 Women who have had multiple sexual partners  
 Women who smoke  
 Women who are immunodeficient  and Women who give birth before age 17years. 
6.2 Screening technique/process 
There are various types of screening test.AS was earlier discussed in this chapter cervical 
cancer is one of the cancers that has meet all the requirement for cancer screening.The methods 
that can be employed for this purpose includes,visual inspection using either Acetic acid or 
Lugos Iodine,Cytological analysis and Human papilloma virous immune assays. 
6.2.1 Types of visual inspection test 
Visual inspection with Acetic Acid or Visual Inspection with Lugols Iodine.The former is the 
one that is commonly use for ease of interpretation. 
6.2.2 Visual inspection with acetic acid (VIA) can be done with the naked eye (also called 
cervicoscopy or direct visual inspection [DVI]), or with low magnification (also called 
gynoscopy, aided VI, or VIAM). 
Visual Inspection with Acetic Acid (VIA)—It more relevant in the developing Nations. 
Visual inspection with acetic acid (VIA) is an attractive screening method for early-    phase 
cervical cancer in underdeveloped countries.It is an acceptable screening method for cervical 
cancer and seems to be an efficient and cost-effective method to detect high-level dysplasia. 
6.3 Test performance: Sensitivity and specificity (Defn) 
Sensitivity: The proportion of all those with disease that the test correctly identifies as 
positive. 
Specificity: The proportion of all those without disease (normal) that the test correctly 
identifies as negative. 
In the screening of cervical cancer, the sensitivity of VIA was high, whereas the 
corresponding specificity was only at an acceptable level. The Positive Predictive Value 
(PPV) and Negative Predictive Value of VIA were found to be high. In other words, the 
validity of VIA during early-phase screening is high in terms of sensitivity and acceptable 
for specificity and predictive values. (Ardahan et al). 
6.4 Technique of VIA 
Performing a vaginal speculum exam is the first step; then the health care provider applies 
dilute (3-5%) acetic acid (vinegar) to the cervix. 
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Abnormal tissue temporarily appears white when exposed to vinegar.  
The cervix  is viewed with the naked eye to identify color changes on the cervix.fig 14 & 15 
Determining whether the test result is positive or negative for possible precancerous lesions 
or cancer and this based on the Aceto-white reactions. 
 
VIA Category Clinical Findings 
Test-negative No acetowhite lesions or faint acetowhite lesions; 
polyp, cervicitis, inflammation, Nabothian cysts. 
Test-positive Sharp, distinct, well-defined, dense (opaque/dull 
or oyster white) acetowhite areas—with or 
without raised margins touching the 
squamocolumnar junction (SCJ); leukoplakia and 
warts. 
Suspicious for cancer Clinically visible ulcerative, cauliflower-like 
growth or ulcer; oozing and/or bleeding on 
contact.fig 16 
 
 
Negative VIA 
 
 
 
Fig. 14. Photo source: JHPIEGO  
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Positive VIA 
   
Fig. 15. Photo source: JHPIEGO 
 
Suspicious Cancer 
 
Fig. 16. Suspicion of carcinoma of the cervix. Photo source: PAHO, Jose Jeronimo          
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6.5 The advantages 
It is Simple, easy-to-learn approach that is minimally reliant upon infrastructure. 
It is not expensive to start-up and the sustaining costs is affordable. 
Many types of health care providers can perform the procedure especially the middle cadre 
of health care providers. 
The Test results are available immediately and as such the issue of follow up is out of the 
question. 
Only requires a single visit. 
It may be possible to integrate VIA screening into primary health care services and it will go 
along way to reduce the incidence and prevalence of carcinoma of the cervix. 
There is a need for developing standard training methods and quality assurance measures. 
This method isLikely to be less accurate among post-menopausal women caution in its 
interpretations. 
6.6 Visual inspection with Lugol’s iodine (VILI) 
Visual inspection with Lugol’s iodine (VILI), also known as Schiller’s test, uses Lugol’s 
iodine instead of acetic acid and it is based on colour change also. 
6.7 Pap smear  
The Pap test was developed by Dr George Papanicolaou an American anatomist in 1944. 
Pap test is used primarily as a tool for screening healthy women for preinvasive cervical 
cancer (CIN) and early invasive cancer.In as much as pap test is a screening tool,it could also 
be use to identify women at risk of cervical cancer. Women with early invasive cancer (FIGO 
Stage 1) are often unaware that they are harbouring the tumour as they are usually 
symptom free. Diagnosis and treatment of invasive cancer while it is still in the early stages 
of development signficantly improves the prognosis (chances of long term survival) of the 
patient. 
It has been proven over time that the cervical smear may be negative even in the presence of 
an advanced  invasive cervical cancer. This is because blood, inflammatory cells and necrotic 
debris from the    cancer  site frequently obscure the abnormal cells in the smear. 
6.8 Specimen sampling 
The sample for pap smear can be collected in three ways 
6.8.1 a) liquid-based cytology (LBC) - using a cyto- brush a device which samples both endo 
and ectocervix. These can be used for preparing conventional smear. Some devices have 
been modified for the preparation of liquid based cytology (LBC) specimens  
6.8.2 b) Papanicolaou (Pap) smear test uses a brush or the Ayres spatula to sample the 
ectocervix. Scraping the ectocervix with  with a modified spatula (the Ayre spatula or a 
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variation of it). This is the most widely used method in developing countries and some part 
of Europe for obtaining material for preparing conventional cervical smears               
6.8.3 c) Using an endocervical brush to sample the endocervix this grossly inadequate and it 
is been discouraged.  
Some of the items required for Pap smear. 
 
 
Fig. 17. Example of Fixatives  
95% ethanol (for fixation)  
80% isopropanol  
95% denatured alcohol 
 
Ayres/Cytobrush 
 
  
Fig. 18. Fixative Jar/Glass slide 
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6.8.4 The step by step approach of Pap test 
1. A speculum must be inserted into vagina and the cervix clearly visualised.The cervical 
os should be  located.  
2. The sampling device(s) used should be selected according to the shape and size of the 
cervix  and the location of the squamocolumnar junction. An Ayre spatula is suitable for 
sampling the cervix in a parous woman ; however a spatula and brush may be needed 
in a post menopausal woman where the squamocolumnar junction lies within the 
endocervical canal.fig 17  
3. The pointed end of the spatula should be  inserted into the cervical os in a nulliparous 
cervix and the rounded end of the spatula inserted into the  patulous os of a parous 
woman. The  device should be  rotated 360 degrees to remove the cells from  the region 
of the transformation zone, squamocolumnar junction and endocervical canal.  
4. The material on the spatula or brush must be transferred immediately to a glass slide 
which has been previously labeled with the patient’s name and date of birth.  
5. The glass slide (fig 18) must be fixed immediately with an appropriate fixative 
(95%alcohol) and the slides transported to the  cytology laboratory in a container  for 
processing together with the corresponding cytology request form.  
6. Samples taken for Liquid Based Cytology should be processed strictly in accordance 
with the manufacturers instructions. After sampling the cervix,  the tip of the sampling 
device should be broken off into the transport medium in the container provided which 
should then be transported to the laboratory for processing if the Surepath method is 
being used. However if the Thinprep method is being used it is of the upmost 
importance that the tip of the sampling device is not included in the container. 
Fixation must be immediate. The smear must not be allowed to dry before fixation. 
Test Limitations as it relates to the sensitivity and specificity and technique of smear. There 
is no difference in specificity, but sensitivity is 12% better with LBC compared with the Pap 
smear, and its "inadequate rate" is only 1.6%, compared with mean of 9.1% with Pap 
smears(Sasieni P etal). Problems include:  
 Variable sampling of appropriate cells from the cervix.  
 Poor transfer of cellular material on to the glass slide.  
 Sub-optimal preparation and fixation by the smear taker. 
6.9 Smear reporting 
It is widely acknowledged that the criteria and terminology used to interpret and report 
cervical smears differs country to country. This has led to problems of communication 
between cytopathologists , cytotechnologists and clinicians and  makes it difficult for 
epidemiologists to make valid comparisons of the effectiveness of the different cervical 
screening programmes. The variability in terminology impedes meaningful discussion 
between laboratories and also affects patient management and the introduction of optimal 
methods of patient care. 
We have the Following reporting methods: 
 a) British Society: In the UK current reporting  guidelines are based on those published 
by the British Society of Clinical Cytology (BSCC) in 1985  
 These are currently under review and new guidelines are expected soon. 
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 b) American (Bethesda) system.: The system of terminology used in the United States 
 First devised in 1988, being revised in 1991 and again in 2001 
 A 2 -tier system which refers to : 
Atypical Squamous Cells of undetermined significance (ASC-US) 
Low grade Squamous intraepithelia neoplasia(LSIL) 
High grade Squamous intraepithelial neoplasia(HSIL)  
 Proposed new BSCC guidelines will bring it in line with the Bethesda system 
Compare and contrast the two (British & American) 
BSCC BETHESDA
Inadequate Unsatisfactory for evaluation
Borderline Nuclear Change ASC-US
ASC- cannot exclude high 
grade
Atypical glandular cells
Mild Dyskaryosis LSIL
Moderate Dyskaryosis HSIL
Severe Dyskaryosis HSIL
Severe Dyskaryosis/?SCC SCC
? Glandular Neoplasia Endocervical Ca in situ
Adenocarcinoma – Endocx., 
Endomet., Extrauterine, NOS
 
Fig. 19. Courtesy of Vanessa Jackson   
7. Cytology report 
7.1 Handling of cytology reports 
 Women with normal smears are offered re-screening at the standard 3-5 year interval - 
follow the advice of your local laboratory. High risk individuals may be screened more 
frequently. Women with moderate or severe dyskaryotic tests need colposcopy ±biopsy. 
Women with borderline or mildly dyskaryotic smears are monitored at a reduced 
screening interval with persistent abnormalities (including persistently inadequate 
smears) needing colposcopy. 
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 Unsatisfactory - Repeat smear four weeks later. 
7.1.1 Inadequate slide  
An inadequate slide may occur as a result of insufficient smear, or when it is adequate it is 
obscured .As much as possible this should be avoided. 
In phase of any abnormal cells, a result of inadequate should not be given rather the 
abnormality should be reported.  
7.1.2 Management of inadequate smear 
It is an indication for a Repeat smear 
 If there is a recognisable infection present the patient should be treatmented before a 
repeat smear is done. 
 After three consecutive inadequate samples, their is a need to  refer such for colposcopic 
assessment. 
7.1.3 Negative 
There should be enough cellular material to cover 1/3 of the slide before a pronouncement 
or report of a negative smear. The report actually makes the woman to be confident that she 
is not at risk of any dysplasia for a period of three years.  
 In atrophic smears, where the cellular material is comprised of parabasal sheets, 10% of 
the slide can be considered adequate. 
 There are no official guidelines for LBC samples. 
It is possible that 15,000 cells will be the standard for adequacy. 
7.1.4 Management of negative slides 
We should give a recommendation of routine recall to our clients. They should be 
encouraged to adhere to this recommendation:  
 Women Age 25-45 should be advised to repeat there smear every three years. While 
those above 45years to 65 should have smear every five years. 
Exceptions: There are exceptions to the above stated rules or recommendation.  
Any patient with Clinical symptoms which are suggestive of immune surpression or are 
immune compromise or have been diagnosed to have immune compromised disease such 
as HIV positive women or women on immune suppressive drugs as in patients with renal 
transplant should have a repeat smear every year/12 months  
The other exception is for those women who may have had the following conditions in the 
past : Post coital bleeding ( PCB),Post menopausal bleeding(PMB),and friable cervix 
All patients on follow up for previous abnormal smears are candidate for repeat based on 
the findings. 
7.1.5 Reporting of infections 
The presence of specific infections may be reported based on the histological features of 
such infections: Such as  
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 Candida 
 Trichomonas – with advice to culture before treatment 
 Herpes Simplex Virus – referral for counselling should be advised 
 Actinomyces – like organisms 
 Follicular Cervicitis – report in younger women 
It is advisable that additional investigations towards definitive diagnosis must be pursued 
before embarking on treatment.   
7.1.6 Follow up of patients on treatment  
The Follow-up of women who have been treated for CIN is very crucial to ensure that there 
is no progression of the disease condition. 
 CIN1 – repeat smears at 6months, 12months and 2years this is the schedule if the smear 
is persistently negative.  
 CIN2 and above –This categories of patients require annual smears for 10 years of 
follow up. 
 CGIN(Cervical Glandular Intraepithelia Neoplasia) – are at greater risk of recurrent 
disease so they are recommended to have smears every 6months for 2years,then 
annually for 10 years  
Follow-up of women with low grade smears but normal colposcopy and no biopsy – require 
a repeat smear at 6 months, 6 months , 12 months, then return to normal recall 
Follow-up of women after hysterectomy for CIN or SCC : 
 Where there was complete excision and the margins were clear of dysplastic cells, vault 
smears should be carried out at 6 months and 18 months before recall can be cancelled as no 
further smears are required. 
In the case of women with incomplete or uncertain excision at hysterectomy, they would 
require follow-up as for women with CIN2 or above. 
In women who have been exposed to radiotherapy as an adjuvant therapy, Smears are not 
advised in this group of women. 
7.1.7 Borderline nuclear change 
This is a “holding” category where there is genuine doubt as to whether or not a smear is 
abnormal. The nuclear changes are not typical and convincing of cervical dyskaryosis and as 
such it can not be labelled as negative. 
Borderline nuclear change is used when wart virus changes are seen on the smear, without 
dyskaryosis.  
It can also be used when severe inflammatory changes exist on the smear, which can 
sometimes appear almost dyskaryotic. 
When interpretation of the smear is difficult e.g. as it is in poor handling or fixing and or 
staining process (such as due to air drying)  
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7.1.8 Management of borderline nuclear change 
The smear should be repeated at 6 months, interval for 1year and 12 months later. – If all are 
negative, normal recall can be resumed. 
If in the course of the follow up, there are a maximum of 3 reports of borderline nuclear 
change in the follow-up period, referral for colposcopy is advised. 
At any point in time One report of borderline glandular cells requires immediate referral for 
further evaluation.. 
In difficult cases, where there is concern that high grade disease may be present, immediate 
referral can be recommended.  
8.1 CIN I/Low sil management 
CIN I/Low SIL correlates to Nucleus occupying up to 1/2 of the area of the 
cell(Nucleocytoplasmic ratio of half)  
8.1.1 Management of mild dyskaryosis  
It is advisable that she should have a colposcopy done,in centres where this facilities are not 
available, “it remains acceptable to recommend a repeat test”.   
If the repeat smear is the same diagnosis (mild dyskaryosis) then a referral must be advised.  
8.2.1 CINII/High SIL 
8.2.2 Cytological features 
CIN II/High SIL correlates to Nucleus occupying up to ½ to 2/3 of the area of the 
cell(Nucleocytoplasmic ratio of ½ to 2/3) 
The Chromatin pattern is usually more abnormal compare to CIN I 
 If a smear is obviously dyskaryotic, but difficult to grade e.g. because there are too few cells 
or they are poorly preserved, it is recommended that they be coded as moderate.  
8.2.3 Management of moderate dyskaryosis 
All patients with moderate dyskaryosis should be referred for colposcopy. 
8.3.1 CIN III/ High SIL 
8.3.2 Cytological features 
CIN III/High SIL correlates to Nucleus occupying more than 2/3 of the area of the 
cell(Nucleocytoplasmic ratio greater than 2/3).The nucleus may have a bizarre shape. 
The Chromatin pattern is usually more abnormal compare to CIN I 
8.3.3 Management of severe dyskaryosis/CIN III/High SIL  
Referral for colposcopy is the standard approach of management.This will include tissue 
biopsy for histology. 
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8.4.1 Invasive squamous carcinoma 
8.4.2 Cytological features 
The histological features are essentially that of Bizarre nuclear changes and keratinisation. 
Diathesis is also a notable findings in this patients. 
8.4.3 Management of invasive squamous carcinoma 
In this case an URGENT referral for colposcopy and tissue diagnosis  is advised. 
9. Treatment of cervical intra-epithelia neoplasia 
9.1 Low grade lesions 
In the treatment of this disease entity a colposcopy,with or without a repeat smear,and or 
tissue biopsy is an essential requirement as stated above. The uses of additional 
investigative tools are very essential in the treatment of this condition. The time interval 
between diagnosis and treatment can be very crucial 
The option of treatment range between Cryotherapy, cold coagulation,Laser agglutination 
therapy and Electrocautery. A lot of caution must be applied to avert over treatment 
especially in young women who are still desirous of conception (over treatment can cause 
fertility problems). 
The follow up schedule as stated above and the patient should be encouraged to adhere to 
this to achieve the desired goal of screening. 
9.2 High grade lesions 
The additional investigations include Colposcopy, repeat smear and tissue biopsy is 
important toward establishing a diagnosis,because the treatment involved is usually 
irreversible. Such  definitive treatment  includes ablative procedures and amputation 
surgeries.  
The definitive treatments include Cold coagulation,Lletz, laser agglutination therapy, 
electrcautery, knife cone biopsy and trachelectomy. 
9.3 Summary of indication for  colposcopy examinations 
The under listed are the patient that would benefit from colposcopy 
 Following 3 consecutive inadequate smears. 
 Women with  clinical symptoms e.g. PMB, friable cervix  
 Post menopausal women with unexplained endometrial cells 
 Women with genital warts.  
 Persistent borderline smears (maximum 3) 
 One report of borderline nuclear change in glandular cells. 
 After 3 abnormal smear results (any grade) in a 10 year period. 
 One report of mild dyskaryosis. 
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 One report of moderate dyskaryosis. 
 One report of severe dyskaryosis. 
 One report of  ? invasive SCC. 
 One report of ? glandular neoplasia. 
 A report of mild or worse in women on follow-up for treated CIN 
10. Human immunosuppressive virus and cervical intra-epithelia neoplasia 
This is actually of more relevance in the developing nations. It’s a major scourge of our time 
that needs to be address at all time and at every given opportunity. 
Follow up in CIN cases is done closely in HIV-positive women: treatment of CIN I has a 
high failure rate in these women, but it has a relatively low rate of progression (Robert Finn 
2011). 
HIV-infected women were 3.7 times more likely to develop CIN than HIV-uninfected 
women. These results highlight the importance of regular cervical cytological screening for 
HIV-Infected women.(Wright) 
The interplay between HIV infection, HPV infection and CIN/cervical cancer is complex 
(see Box 34.1). Cervical dysplasia and possibly invasive cervical cancer are more prevalent in 
HIV-positive women. The latter has a higher rate of HPV infections which are strongly 
associated with high-grade SIL and invasive cervical cancer.(Sun et al 1997) Immune 
suppression is the factor predisposing HIV positive women to HPV infections fig 20. CIN is 
commoner in HIV infected women with a lower CD4 count or AIDS. (Sun et al 1995) have 
suggested that the presence of immunosuppression shifts the ratio of latent: clinically 
expressed HPV infection from 8:1 in the general population to 3:1 in HIV-positive women 
with CD4 >500/μL and to 1:1 when CD4<200/μL. Linking the US AIDS and Cancer 
Registry, the observed cervical cancer cases in HIV infected women were up to 9 folds 
higher than the expected number of cases but the likelihood of cervical cancer is not related 
to the CD4 count. (mbulaiteye et al2003). 
The screening process for the HIV positive patients differs significantly based on the prelude 
of our discussion and as such the have the following schedules: 
Pelvic examination and Pap smear are repeated six months after the baseline.(Anderson 
2005) If both times are normal, cervical screening is then performed every twelve months 
alongside with careful vulval, vaginal and anal inspections. There is no specific CD4 
threshold under which the frequency of Pap smear would need to be increased, though this 
may be considered in cases of(Anderson 2005)  
a. Previous abnormal Pap smear  
b. HPV infection  
c. Symptomatic HIV disease  
d. CD4 counts <200/μL  
e. Post-treatment for CIN  
Other forms of screening may be employed in the management of those who are positive for 
HIV. HPV-DNA has recently been introduced as one form of screening. As there is a high 
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incidence of HPV infection in HIV patient and most HIV patients with abnormal smear will 
ultimately need colposcopy evaluation (to rule out CIN and cervical cancer), the use of 
HPV-DNA in the triage for colposcopy is of limited value and it is not cost effective. On the 
other hand, despite the higher incidence of cervical abnormality in HIV infected patients, 
colposcopy is not generally recommended for primary cervical screening (Anderson et al 
2005) but indicated when pap smear reveals epithelial cell abnormality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20. (Courtesy Siu-Keung LAM) Relationship Between HIV,HPV & CIN 1 
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Fig. 21. (Courtesy of Siu-Keung LAM) 
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10.1 Management of cervical lesion in HIV positive patients 
HIV-infected patients with ASC-US cervical lesion or above once on Pap smear should be 
referred for colposcopy. At a colposcopy clinic, thorough evaluation of the lower genital 
tract is performed including colposcopy and cervical biopsy at the most suspicious area to 
rule out CIN and/or malignancy. If there is no HGSIL, patients are followed up regularly in 
the colposcopy clinic. If HGSIL is found, most patients require large loop excision of 
transformation zone (LLETZ), to reduce the chance of progression to cervical cancer. This 
has to be coupled with regular post-treatment cervical smear surveillance as stated above. 
The other forms of therapy that can be use includes, Laser agglutination 
therapy,Electrocautery and cone biopsy of the cervix. The role of HAART in preventing CIN 
recurrence post treatment is still controversial,but it is adviced that it should be given.( Siu-
Keung LAM) 
11. HPV vaccination and cervical intra-epithelia neoplasia 
In a randomised control study (double blinded) it was concluded that, In young women 
who have not been previously infected with human papillomavirus-16 (HPV16), 
vaccination prevents HPV16-related cervical intra-epithelial neoplasia (CIN).(Mao et al 
2006). 
It should be noted that only 75% of all cervical cancers are caused the HPV viruses 16 and 
18,it is therefore still possible for a woman to develop cervical cancer even though they are 
immunised. This is because there are other sero types of HPV not covered by those vaccine 
in the market. 
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